10-QPeriod: Q2 FY1996

MCKESSON CORP Quarterly Report for Q2 Ended Sep 30, 1995

Filed November 13, 1995For Securities:MCK

Summary

McKesson Corporation's 10-Q filing for the period ending September 29, 1995, indicates a company operating within the pharmaceutical distribution sector. As this is a historical filing from 1995, it provides a snapshot of the company's performance and financial position during that specific quarter, over two decades ago. Investors would need to consider this context carefully, as the company and its competitive landscape have evolved significantly since this filing. The report details the company's financial results and operational status during this three-month period. While the provided text is a directory listing and not the full financial report, it signifies McKesson's compliance with SEC reporting requirements. For a comprehensive understanding, access to the full 10-Q document (likely the .txt file referenced) is crucial. This would reveal key financial metrics such as revenue, net income, assets, liabilities, and cash flows, as well as management's discussion and analysis of the results.

Key Highlights

  • 1McKesson Corporation filed its quarterly report (10-Q) for the period ending September 29, 1995, on November 12, 1995.
  • 2The filing is a standard SEC disclosure providing financial and operational information for the specified quarter.
  • 3This report provides a historical financial snapshot of McKesson Corporation from over 25 years ago.
  • 4The context of 1995 is critical, as the pharmaceutical industry and McKesson's business have undergone substantial changes since then.
  • 5Investors interested in historical performance would need to access the full 10-Q filing (indicated by the .txt file) for detailed financial data.
  • 6The provided text is a directory listing of the filing's components, not the financial statements themselves.

Frequently Asked Questions

Based on its name and typical operations of the era, McKesson Corporation is understood to be involved in the pharmaceutical distribution sector, although the provided text is a directory listing and not the full report itself. Investors would need to consult the actual 10-Q document for definitive business segment details.

The provided text is a directory listing and does not contain the financial statements. To understand McKesson's financial performance, investors would need to access and review the full 10-Q filing, typically found in the .txt file, which would detail revenue, expenses, assets, liabilities, and cash flows for the quarter ending September 29, 1995.

This filing is of historical interest primarily. The business environment, regulatory landscape, and McKesson's operations have evolved dramatically over the past 25+ years. It is not directly indicative of the company's current financial health or future prospects, but it offers insight into its past performance and strategic positioning.

The complete financial data would be contained within the full 10-Q filing document. The directory listing indicates a file named '-95-000011.txt', which is likely the primary document containing the financial statements and management's discussion and analysis.